Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

27.79 -0.29 (-1.03%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amylyx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Amylyx: An "Ice Bucket" Buy ↗

November 06, 2022

The drug was green-lighted by the Food & Drug Administration last month, after clinical trials partially funded by Ice Bucket Challenge grants showed that Relyvrio takers had a median survival period...

Via Talk Markets

Amylyx Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 10, 2022

November 03, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Cytokinetics CEO: Why It's OK Not Being An Overnight Success ↗

October 25, 2022

The company hopes to come out next year with at least one heart-failure drug.

Via Investor's Business Daily

Amylyx Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

October 11, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Where Amylyx Pharma Stands With Analysts ↗

October 03, 2022

Analysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:

Via Benzinga

4 Analysts Have This to Say About Amylyx Pharma ↗

September 08, 2022

Analysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:

Via Benzinga

After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful ↗

September 08, 2022

Via Benzinga

Amylyx Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

October 06, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals Announces Launch of Public Offering

October 04, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Vyant Bio Inc. (NASDAQ: VYNT): Leading a New Biotech Move to Combat Diseases Affecting the Nervous System ↗

October 04, 2022

Biotechnology companies such as Biogen Inc. (NASDAQ: BIIB), Alector Inc.

Via Benzinga

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗

October 02, 2022

Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Bounce In Futures Fizzles As Dollar Surge Returns ↗

September 30, 2022

In premarket trading, Nike shares fall 10% after the sportswear giant cut its margin outlook for the year while reporting surging inventory, fueling worries over consumers’ ability to spend as...

Via Talk Markets

Why Is IONQ Stock Up 8% Today? ↗

September 30, 2022

IonQ (IONQ) stock is climbing higher on Friday after the company announced it secured a $13.4 million contract with the AFRL.

Via InvestorPlace

AMLX Stock Alert: Amylyx Pharma Gains on Huge FDA Win ↗

September 30, 2022

Shares of Amylyx Pharma are popping today on news that the FDA has greenlit its treatment against the deadly disease ALS.

Via InvestorPlace

Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket ↗

September 30, 2022

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining...

Via Benzinga

Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS

September 29, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A Long Battle ↗

September 29, 2022

The drug has faced two advisory committees and a delayed review date.

Via Investor's Business Daily

Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test ↗

September 29, 2022

Patients didn't show any improvements in a study meant to test multiple drugs.

Via Investor's Business Daily

Amylyx Pharmaceuticals Announces Donated CENTAUR Clinical Trial Data Now Available to Help Advance Science in ALS for Future Treatments and Discoveries

September 14, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals Announces Publication of Preclinical Data Showing Potential Synergistic Effect of AMX0035 Compared to Individual Compounds

September 12, 2022

From Amylyx Pharmaceuticals

Via Business Wire

Amylyx Pharmaceuticals Stock Sees Relative Strength Rating Rise To 98 ↗

September 09, 2022

Amylyx Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating improve to 98, up from 83 the day before.

Via Investor's Business Daily

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

US Stocks Flat, Crude Oil Rises 2% ↗

September 08, 2022

U.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data.

Via Benzinga

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

September 08, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

Via Benzinga

US Stocks Turn Higher, Nasdaq Jumps 100 Points ↗

September 08, 2022

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.

Via Benzinga

AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday ↗

September 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

AAPL Stock Alert: 13 Takeaways From the Latest Apple Event 2022 ↗

September 08, 2022

Apple (AAPL) stock is a hot topic on Thursday following the tech giant's latest event showing off new products and we've got the details!

Via InvestorPlace

Dow Drops 100 Points; US Jobless Claims Fall Further Last Week ↗

September 08, 2022

U.S. stocks traded mostly lower this morning, with the Dow Jones dropping 100 points on Thursday.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.